Kinesiophobia in Women With Stress Urinary Incontinence

August 4, 2026 updated by: Esra BAYRAMOĞLU DEMİRDÖĞEN
All women included in the study will be administered the Causes of Kinesiophobia Scale (KCS), the International Physical Activity Questionnaire (Short), the International Incontinence Consultation Questionnaire-Short Form (ICIQ-SF), and the Pittsburgh Sleep Quality Questionnaire (PSQI). Subsequent analysis will determine the causes of kinesiophobia in women with urinary incontinence.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

All women included in the study will be administered the Causes of Kinesiophobia Scale (KCS), the International Physical Activity Questionnaire (Short), the International Incontinence Consultation Questionnaire-Short Form (ICIQ-SF), and the Pittsburgh Sleep Quality Questionnaire (PSQI). Subsequent analysis will determine the causes of kinesiophobia in women with urinary incontinence. The results will then be compared with those of healthy women.

Study Type

Observational

Enrollment (Actual)

115

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Centre
      • Kırşehir, Centre, Turkey (Türkiye), 40000
        • Kirşehir Ahi Evran University Physical Therapy and Rehabilitation Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

women with stress urinary incontinence

Description

Inclusion Criteria:

  1. Being between 18-65 years old
  2. Having stress urinary incontinence
  3. Voluntary participation in the study

Exclusion Criteria:

  1. Unwillingness to continue working
  2. Presence of neurological or orthopedic disease
  3. Learning disability or other cognitive impairments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control
Healthy
Other: Survey
survey
Stress Urinary Incontinence
intervention
Other: Survey
survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kinesiophobia
Time Frame: day 1
Kinesiophobia, or fear of movement, in patients will be assessed using the Causes of Kinesiophobia Scale. This scale consists of 20 questions and evaluates the fear of movement in two subcategories: biological and psychological causes.
day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Esra BAYRAMOĞLU DEMİRDÖĞEN

Investigators

  • Principal Investigator: ESRA bayramoğlu demirdöğen, Kirsehir Ahi Evran Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2025

Primary Completion (Actual)

January 20, 2026

Study Completion (Actual)

February 10, 2026

Study Registration Dates

First Submitted

December 21, 2025

First Submitted That Met QC Criteria

January 5, 2026

First Posted (Actual)

January 9, 2026

Study Record Updates

Last Update Posted (Actual)

August 6, 2026

Last Update Submitted That Met QC Criteria

August 4, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KAEU-EBAYRAMOGLUD-005

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe